Global Porcine Epidemic Diarrhea Vaccines

Porcine Epidemic Diarrhea Vaccines Comprehensive Study by Type (Live, Killed), Application (Adult Pigs, Piglets), End Users (Veterinary Hospitals, Hog Production Farm) Players and Region - Global Market Outlook to 2026

Porcine Epidemic Diarrhea Vaccines Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Porcine Epidemic Diarrhea Vaccines Market?

Porcine epidemic diarrhoea virus (PEDV), a member of the class Alphacoronavirus in the family Coronaviridae of the order Nidovirales, induces intense gastrointestinal symptoms characterized by dehydration, vomiting, diarrhea, and high mortality in infant and suckling piglets. PEDV is presently one of the most destroying porcine infections that has emerged or re-emerged, showing a significant danger to the worldwide pork industry. Immunization of pregnant sow is important for controlling the Porcine epidemic diarrhoea epidemic & minimising the number of deaths in breastfeeding piglets. Several live and killed PED vaccines which can be administered to sows are already commercially available in the market.

The market study is being classified by Type (Live and Killed), by Application (Adult Pigs and Piglets) and major geographies with country level break-up.

Cavac (France), Green Cross Zoetis Products (South Korea), Harrisvaccines, Inc. (United States), Komipharm (South Korea), Nisseiken Co. Ltd. (Japan), Qilu Animal Health (China), KM Biologics Co. Ltd (United States) and Bayer AG (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Zoetis (United States), Ceva Sante Animale (France) and Aptimmune Biologics Inc. (United States).

The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns and need, and frequent changes in consumer health issues pose significant opportunities for market growth. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Porcine Epidemic Diarrhea Vaccines market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Porcine Epidemic Diarrhea Vaccines market by Type, Application and Region.

On the basis of geography, the market of Porcine Epidemic Diarrhea Vaccines has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Rise in Number of Pig Farms
  • Rise in Swine Diseases
  • Rapid Increase in Contract Farming and Independent Farming for Pig Cultivation
  • High Consumption of Pork Meat

Market Trend
  • Increased R&D Activities by Pharmaceutical Companies

Restraints
  • Supply Chain and Logistics

Opportunities
  • High Growth Opportunities for Major Key Players for Setting up Their Vaccine Manufacturing Plant in Untapped Countries

Challenges
  • The COVID-19 Pandemic



The Destruction and Disposal of Dead Animals Control requires that animals that have died from a reportable infection must be disposed of in accordance with the course of an Agriculture and Forestry veterinary examiner. Natural disposal is strictly prohibited.

Key Target Audience
Porcine vaccines manufacturers, Porcine vaccines suppliers, Private research laboratories, Research and development (R&D) companies, Market research and consulting service providers, Government research laboratories and Contract manufacturing organizations

Report Objectives / Segmentation Covered

By Type
  • Live
  • Killed
By Application
  • Adult Pigs
  • Piglets
By End Users
  • Veterinary Hospitals
  • Hog Production Farm

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rise in Number of Pig Farms
      • 3.2.2. Rise in Swine Diseases
      • 3.2.3. Rapid Increase in Contract Farming and Independent Farming for Pig Cultivation
      • 3.2.4. High Consumption of Pork Meat
    • 3.3. Market Challenges
      • 3.3.1. The COVID-19 Pandemic
    • 3.4. Market Trends
      • 3.4.1. Increased R&D Activities by Pharmaceutical Companies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Porcine Epidemic Diarrhea Vaccines, by Type, Application, End Users and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Porcine Epidemic Diarrhea Vaccines (Value)
      • 5.2.1. Global Porcine Epidemic Diarrhea Vaccines by: Type (Value)
        • 5.2.1.1. Live
        • 5.2.1.2. Killed
      • 5.2.2. Global Porcine Epidemic Diarrhea Vaccines by: Application (Value)
        • 5.2.2.1. Adult Pigs
        • 5.2.2.2. Piglets
      • 5.2.3. Global Porcine Epidemic Diarrhea Vaccines by: End Users (Value)
        • 5.2.3.1. Veterinary Hospitals
        • 5.2.3.2. Hog Production Farm
      • 5.2.4. Global Porcine Epidemic Diarrhea Vaccines Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Porcine Epidemic Diarrhea Vaccines (Volume)
      • 5.3.1. Global Porcine Epidemic Diarrhea Vaccines by: Type (Volume)
        • 5.3.1.1. Live
        • 5.3.1.2. Killed
      • 5.3.2. Global Porcine Epidemic Diarrhea Vaccines by: Application (Volume)
        • 5.3.2.1. Adult Pigs
        • 5.3.2.2. Piglets
      • 5.3.3. Global Porcine Epidemic Diarrhea Vaccines by: End Users (Volume)
        • 5.3.3.1. Veterinary Hospitals
        • 5.3.3.2. Hog Production Farm
      • 5.3.4. Global Porcine Epidemic Diarrhea Vaccines Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Porcine Epidemic Diarrhea Vaccines (Price)
      • 5.4.1. Global Porcine Epidemic Diarrhea Vaccines by: Type (Price)
  • 6. Porcine Epidemic Diarrhea Vaccines: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Cavac (France)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Green Cross Zoetis Products (South Korea)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Harrisvaccines, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Komipharm (South Korea)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Nisseiken Co. Ltd. (Japan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Qilu Animal Health (China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. KM Biologics Co. Ltd (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Bayer AG (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Porcine Epidemic Diarrhea Vaccines Sale, by Type, Application, End Users and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Porcine Epidemic Diarrhea Vaccines (Value)
      • 7.2.1. Global Porcine Epidemic Diarrhea Vaccines by: Type (Value)
        • 7.2.1.1. Live
        • 7.2.1.2. Killed
      • 7.2.2. Global Porcine Epidemic Diarrhea Vaccines by: Application (Value)
        • 7.2.2.1. Adult Pigs
        • 7.2.2.2. Piglets
      • 7.2.3. Global Porcine Epidemic Diarrhea Vaccines by: End Users (Value)
        • 7.2.3.1. Veterinary Hospitals
        • 7.2.3.2. Hog Production Farm
      • 7.2.4. Global Porcine Epidemic Diarrhea Vaccines Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Porcine Epidemic Diarrhea Vaccines (Volume)
      • 7.3.1. Global Porcine Epidemic Diarrhea Vaccines by: Type (Volume)
        • 7.3.1.1. Live
        • 7.3.1.2. Killed
      • 7.3.2. Global Porcine Epidemic Diarrhea Vaccines by: Application (Volume)
        • 7.3.2.1. Adult Pigs
        • 7.3.2.2. Piglets
      • 7.3.3. Global Porcine Epidemic Diarrhea Vaccines by: End Users (Volume)
        • 7.3.3.1. Veterinary Hospitals
        • 7.3.3.2. Hog Production Farm
      • 7.3.4. Global Porcine Epidemic Diarrhea Vaccines Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Porcine Epidemic Diarrhea Vaccines (Price)
      • 7.4.1. Global Porcine Epidemic Diarrhea Vaccines by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Porcine Epidemic Diarrhea Vaccines: by Type(USD Million)
  • Table 2. Porcine Epidemic Diarrhea Vaccines Live , by Region USD Million (2015-2020)
  • Table 3. Porcine Epidemic Diarrhea Vaccines Killed , by Region USD Million (2015-2020)
  • Table 4. Porcine Epidemic Diarrhea Vaccines: by Application(USD Million)
  • Table 5. Porcine Epidemic Diarrhea Vaccines Adult Pigs , by Region USD Million (2015-2020)
  • Table 6. Porcine Epidemic Diarrhea Vaccines Piglets , by Region USD Million (2015-2020)
  • Table 7. Porcine Epidemic Diarrhea Vaccines: by End Users(USD Million)
  • Table 8. Porcine Epidemic Diarrhea Vaccines Veterinary Hospitals , by Region USD Million (2015-2020)
  • Table 9. Porcine Epidemic Diarrhea Vaccines Hog Production Farm , by Region USD Million (2015-2020)
  • Table 10. South America Porcine Epidemic Diarrhea Vaccines, by Country USD Million (2015-2020)
  • Table 11. South America Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2015-2020)
  • Table 12. South America Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2015-2020)
  • Table 13. South America Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2015-2020)
  • Table 14. Brazil Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2015-2020)
  • Table 15. Brazil Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2015-2020)
  • Table 16. Brazil Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2015-2020)
  • Table 17. Argentina Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2015-2020)
  • Table 18. Argentina Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2015-2020)
  • Table 19. Argentina Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2015-2020)
  • Table 20. Rest of South America Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2015-2020)
  • Table 21. Rest of South America Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2015-2020)
  • Table 22. Rest of South America Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2015-2020)
  • Table 23. Asia Pacific Porcine Epidemic Diarrhea Vaccines, by Country USD Million (2015-2020)
  • Table 24. Asia Pacific Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2015-2020)
  • Table 25. Asia Pacific Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2015-2020)
  • Table 26. Asia Pacific Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2015-2020)
  • Table 27. China Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2015-2020)
  • Table 28. China Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2015-2020)
  • Table 29. China Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2015-2020)
  • Table 30. Japan Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2015-2020)
  • Table 31. Japan Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2015-2020)
  • Table 32. Japan Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2015-2020)
  • Table 33. India Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2015-2020)
  • Table 34. India Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2015-2020)
  • Table 35. India Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2015-2020)
  • Table 36. South Korea Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2015-2020)
  • Table 37. South Korea Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2015-2020)
  • Table 38. South Korea Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2015-2020)
  • Table 39. Taiwan Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2015-2020)
  • Table 40. Taiwan Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2015-2020)
  • Table 41. Taiwan Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2015-2020)
  • Table 42. Australia Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2015-2020)
  • Table 43. Australia Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2015-2020)
  • Table 44. Australia Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2015-2020)
  • Table 45. Rest of Asia-Pacific Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2015-2020)
  • Table 46. Rest of Asia-Pacific Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2015-2020)
  • Table 47. Rest of Asia-Pacific Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2015-2020)
  • Table 48. Europe Porcine Epidemic Diarrhea Vaccines, by Country USD Million (2015-2020)
  • Table 49. Europe Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2015-2020)
  • Table 50. Europe Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2015-2020)
  • Table 51. Europe Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2015-2020)
  • Table 52. Germany Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2015-2020)
  • Table 53. Germany Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2015-2020)
  • Table 54. Germany Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2015-2020)
  • Table 55. France Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2015-2020)
  • Table 56. France Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2015-2020)
  • Table 57. France Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2015-2020)
  • Table 58. Italy Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2015-2020)
  • Table 59. Italy Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2015-2020)
  • Table 60. Italy Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2015-2020)
  • Table 61. United Kingdom Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2015-2020)
  • Table 62. United Kingdom Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2015-2020)
  • Table 63. United Kingdom Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2015-2020)
  • Table 64. Netherlands Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2015-2020)
  • Table 65. Netherlands Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2015-2020)
  • Table 66. Netherlands Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2015-2020)
  • Table 67. Rest of Europe Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2015-2020)
  • Table 68. Rest of Europe Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2015-2020)
  • Table 69. Rest of Europe Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2015-2020)
  • Table 70. MEA Porcine Epidemic Diarrhea Vaccines, by Country USD Million (2015-2020)
  • Table 71. MEA Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2015-2020)
  • Table 72. MEA Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2015-2020)
  • Table 73. MEA Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2015-2020)
  • Table 74. Middle East Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2015-2020)
  • Table 75. Middle East Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2015-2020)
  • Table 76. Middle East Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2015-2020)
  • Table 77. Africa Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2015-2020)
  • Table 78. Africa Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2015-2020)
  • Table 79. Africa Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2015-2020)
  • Table 80. North America Porcine Epidemic Diarrhea Vaccines, by Country USD Million (2015-2020)
  • Table 81. North America Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2015-2020)
  • Table 82. North America Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2015-2020)
  • Table 83. North America Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2015-2020)
  • Table 84. United States Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2015-2020)
  • Table 85. United States Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2015-2020)
  • Table 86. United States Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2015-2020)
  • Table 87. Canada Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2015-2020)
  • Table 88. Canada Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2015-2020)
  • Table 89. Canada Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2015-2020)
  • Table 90. Mexico Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2015-2020)
  • Table 91. Mexico Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2015-2020)
  • Table 92. Mexico Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2015-2020)
  • Table 93. Porcine Epidemic Diarrhea Vaccines Sales: by Type(K Units)
  • Table 94. Porcine Epidemic Diarrhea Vaccines Sales Live , by Region K Units (2015-2020)
  • Table 95. Porcine Epidemic Diarrhea Vaccines Sales Killed , by Region K Units (2015-2020)
  • Table 96. Porcine Epidemic Diarrhea Vaccines Sales: by Application(K Units)
  • Table 97. Porcine Epidemic Diarrhea Vaccines Sales Adult Pigs , by Region K Units (2015-2020)
  • Table 98. Porcine Epidemic Diarrhea Vaccines Sales Piglets , by Region K Units (2015-2020)
  • Table 99. Porcine Epidemic Diarrhea Vaccines Sales: by End Users(K Units)
  • Table 100. Porcine Epidemic Diarrhea Vaccines Sales Veterinary Hospitals , by Region K Units (2015-2020)
  • Table 101. Porcine Epidemic Diarrhea Vaccines Sales Hog Production Farm , by Region K Units (2015-2020)
  • Table 102. South America Porcine Epidemic Diarrhea Vaccines Sales, by Country K Units (2015-2020)
  • Table 103. South America Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2015-2020)
  • Table 104. South America Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2015-2020)
  • Table 105. South America Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2015-2020)
  • Table 106. Brazil Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2015-2020)
  • Table 107. Brazil Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2015-2020)
  • Table 108. Brazil Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2015-2020)
  • Table 109. Argentina Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2015-2020)
  • Table 110. Argentina Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2015-2020)
  • Table 111. Argentina Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2015-2020)
  • Table 112. Rest of South America Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2015-2020)
  • Table 113. Rest of South America Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2015-2020)
  • Table 114. Rest of South America Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2015-2020)
  • Table 115. Asia Pacific Porcine Epidemic Diarrhea Vaccines Sales, by Country K Units (2015-2020)
  • Table 116. Asia Pacific Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2015-2020)
  • Table 117. Asia Pacific Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2015-2020)
  • Table 118. Asia Pacific Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2015-2020)
  • Table 119. China Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2015-2020)
  • Table 120. China Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2015-2020)
  • Table 121. China Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2015-2020)
  • Table 122. Japan Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2015-2020)
  • Table 123. Japan Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2015-2020)
  • Table 124. Japan Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2015-2020)
  • Table 125. India Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2015-2020)
  • Table 126. India Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2015-2020)
  • Table 127. India Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2015-2020)
  • Table 128. South Korea Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2015-2020)
  • Table 129. South Korea Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2015-2020)
  • Table 130. South Korea Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2015-2020)
  • Table 131. Taiwan Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2015-2020)
  • Table 132. Taiwan Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2015-2020)
  • Table 133. Taiwan Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2015-2020)
  • Table 134. Australia Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2015-2020)
  • Table 135. Australia Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2015-2020)
  • Table 136. Australia Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2015-2020)
  • Table 137. Rest of Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2015-2020)
  • Table 138. Rest of Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2015-2020)
  • Table 139. Rest of Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2015-2020)
  • Table 140. Europe Porcine Epidemic Diarrhea Vaccines Sales, by Country K Units (2015-2020)
  • Table 141. Europe Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2015-2020)
  • Table 142. Europe Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2015-2020)
  • Table 143. Europe Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2015-2020)
  • Table 144. Germany Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2015-2020)
  • Table 145. Germany Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2015-2020)
  • Table 146. Germany Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2015-2020)
  • Table 147. France Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2015-2020)
  • Table 148. France Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2015-2020)
  • Table 149. France Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2015-2020)
  • Table 150. Italy Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2015-2020)
  • Table 151. Italy Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2015-2020)
  • Table 152. Italy Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2015-2020)
  • Table 153. United Kingdom Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2015-2020)
  • Table 154. United Kingdom Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2015-2020)
  • Table 155. United Kingdom Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2015-2020)
  • Table 156. Netherlands Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2015-2020)
  • Table 157. Netherlands Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2015-2020)
  • Table 158. Netherlands Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2015-2020)
  • Table 159. Rest of Europe Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2015-2020)
  • Table 160. Rest of Europe Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2015-2020)
  • Table 161. Rest of Europe Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2015-2020)
  • Table 162. MEA Porcine Epidemic Diarrhea Vaccines Sales, by Country K Units (2015-2020)
  • Table 163. MEA Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2015-2020)
  • Table 164. MEA Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2015-2020)
  • Table 165. MEA Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2015-2020)
  • Table 166. Middle East Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2015-2020)
  • Table 167. Middle East Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2015-2020)
  • Table 168. Middle East Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2015-2020)
  • Table 169. Africa Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2015-2020)
  • Table 170. Africa Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2015-2020)
  • Table 171. Africa Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2015-2020)
  • Table 172. North America Porcine Epidemic Diarrhea Vaccines Sales, by Country K Units (2015-2020)
  • Table 173. North America Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2015-2020)
  • Table 174. North America Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2015-2020)
  • Table 175. North America Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2015-2020)
  • Table 176. United States Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2015-2020)
  • Table 177. United States Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2015-2020)
  • Table 178. United States Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2015-2020)
  • Table 179. Canada Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2015-2020)
  • Table 180. Canada Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2015-2020)
  • Table 181. Canada Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2015-2020)
  • Table 182. Mexico Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2015-2020)
  • Table 183. Mexico Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2015-2020)
  • Table 184. Mexico Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2015-2020)
  • Table 185. Porcine Epidemic Diarrhea Vaccines: by Type(USD/Units)
  • Table 186. Company Basic Information, Sales Area and Its Competitors
  • Table 187. Company Basic Information, Sales Area and Its Competitors
  • Table 188. Company Basic Information, Sales Area and Its Competitors
  • Table 189. Company Basic Information, Sales Area and Its Competitors
  • Table 190. Company Basic Information, Sales Area and Its Competitors
  • Table 191. Company Basic Information, Sales Area and Its Competitors
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Porcine Epidemic Diarrhea Vaccines: by Type(USD Million)
  • Table 195. Porcine Epidemic Diarrhea Vaccines Live , by Region USD Million (2021-2026)
  • Table 196. Porcine Epidemic Diarrhea Vaccines Killed , by Region USD Million (2021-2026)
  • Table 197. Porcine Epidemic Diarrhea Vaccines: by Application(USD Million)
  • Table 198. Porcine Epidemic Diarrhea Vaccines Adult Pigs , by Region USD Million (2021-2026)
  • Table 199. Porcine Epidemic Diarrhea Vaccines Piglets , by Region USD Million (2021-2026)
  • Table 200. Porcine Epidemic Diarrhea Vaccines: by End Users(USD Million)
  • Table 201. Porcine Epidemic Diarrhea Vaccines Veterinary Hospitals , by Region USD Million (2021-2026)
  • Table 202. Porcine Epidemic Diarrhea Vaccines Hog Production Farm , by Region USD Million (2021-2026)
  • Table 203. South America Porcine Epidemic Diarrhea Vaccines, by Country USD Million (2021-2026)
  • Table 204. South America Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2021-2026)
  • Table 205. South America Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2021-2026)
  • Table 206. South America Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2021-2026)
  • Table 207. Brazil Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2021-2026)
  • Table 208. Brazil Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2021-2026)
  • Table 209. Brazil Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2021-2026)
  • Table 210. Argentina Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2021-2026)
  • Table 211. Argentina Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2021-2026)
  • Table 212. Argentina Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2021-2026)
  • Table 213. Rest of South America Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2021-2026)
  • Table 214. Rest of South America Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2021-2026)
  • Table 215. Rest of South America Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2021-2026)
  • Table 216. Asia Pacific Porcine Epidemic Diarrhea Vaccines, by Country USD Million (2021-2026)
  • Table 217. Asia Pacific Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2021-2026)
  • Table 218. Asia Pacific Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2021-2026)
  • Table 219. Asia Pacific Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2021-2026)
  • Table 220. China Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2021-2026)
  • Table 221. China Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2021-2026)
  • Table 222. China Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2021-2026)
  • Table 223. Japan Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2021-2026)
  • Table 224. Japan Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2021-2026)
  • Table 225. Japan Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2021-2026)
  • Table 226. India Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2021-2026)
  • Table 227. India Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2021-2026)
  • Table 228. India Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2021-2026)
  • Table 229. South Korea Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2021-2026)
  • Table 230. South Korea Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2021-2026)
  • Table 231. South Korea Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2021-2026)
  • Table 232. Taiwan Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2021-2026)
  • Table 233. Taiwan Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2021-2026)
  • Table 234. Taiwan Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2021-2026)
  • Table 235. Australia Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2021-2026)
  • Table 236. Australia Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2021-2026)
  • Table 237. Australia Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2021-2026)
  • Table 238. Rest of Asia-Pacific Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2021-2026)
  • Table 239. Rest of Asia-Pacific Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2021-2026)
  • Table 240. Rest of Asia-Pacific Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2021-2026)
  • Table 241. Europe Porcine Epidemic Diarrhea Vaccines, by Country USD Million (2021-2026)
  • Table 242. Europe Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2021-2026)
  • Table 243. Europe Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2021-2026)
  • Table 244. Europe Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2021-2026)
  • Table 245. Germany Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2021-2026)
  • Table 246. Germany Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2021-2026)
  • Table 247. Germany Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2021-2026)
  • Table 248. France Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2021-2026)
  • Table 249. France Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2021-2026)
  • Table 250. France Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2021-2026)
  • Table 251. Italy Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2021-2026)
  • Table 252. Italy Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2021-2026)
  • Table 253. Italy Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2021-2026)
  • Table 254. United Kingdom Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2021-2026)
  • Table 255. United Kingdom Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2021-2026)
  • Table 256. United Kingdom Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2021-2026)
  • Table 257. Netherlands Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2021-2026)
  • Table 258. Netherlands Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2021-2026)
  • Table 259. Netherlands Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2021-2026)
  • Table 260. Rest of Europe Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2021-2026)
  • Table 261. Rest of Europe Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2021-2026)
  • Table 262. Rest of Europe Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2021-2026)
  • Table 263. MEA Porcine Epidemic Diarrhea Vaccines, by Country USD Million (2021-2026)
  • Table 264. MEA Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2021-2026)
  • Table 265. MEA Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2021-2026)
  • Table 266. MEA Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2021-2026)
  • Table 267. Middle East Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2021-2026)
  • Table 268. Middle East Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2021-2026)
  • Table 269. Middle East Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2021-2026)
  • Table 270. Africa Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2021-2026)
  • Table 271. Africa Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2021-2026)
  • Table 272. Africa Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2021-2026)
  • Table 273. North America Porcine Epidemic Diarrhea Vaccines, by Country USD Million (2021-2026)
  • Table 274. North America Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2021-2026)
  • Table 275. North America Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2021-2026)
  • Table 276. North America Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2021-2026)
  • Table 277. United States Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2021-2026)
  • Table 278. United States Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2021-2026)
  • Table 279. United States Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2021-2026)
  • Table 280. Canada Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2021-2026)
  • Table 281. Canada Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2021-2026)
  • Table 282. Canada Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2021-2026)
  • Table 283. Mexico Porcine Epidemic Diarrhea Vaccines, by Type USD Million (2021-2026)
  • Table 284. Mexico Porcine Epidemic Diarrhea Vaccines, by Application USD Million (2021-2026)
  • Table 285. Mexico Porcine Epidemic Diarrhea Vaccines, by End Users USD Million (2021-2026)
  • Table 286. Porcine Epidemic Diarrhea Vaccines Sales: by Type(K Units)
  • Table 287. Porcine Epidemic Diarrhea Vaccines Sales Live , by Region K Units (2021-2026)
  • Table 288. Porcine Epidemic Diarrhea Vaccines Sales Killed , by Region K Units (2021-2026)
  • Table 289. Porcine Epidemic Diarrhea Vaccines Sales: by Application(K Units)
  • Table 290. Porcine Epidemic Diarrhea Vaccines Sales Adult Pigs , by Region K Units (2021-2026)
  • Table 291. Porcine Epidemic Diarrhea Vaccines Sales Piglets , by Region K Units (2021-2026)
  • Table 292. Porcine Epidemic Diarrhea Vaccines Sales: by End Users(K Units)
  • Table 293. Porcine Epidemic Diarrhea Vaccines Sales Veterinary Hospitals , by Region K Units (2021-2026)
  • Table 294. Porcine Epidemic Diarrhea Vaccines Sales Hog Production Farm , by Region K Units (2021-2026)
  • Table 295. South America Porcine Epidemic Diarrhea Vaccines Sales, by Country K Units (2021-2026)
  • Table 296. South America Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2021-2026)
  • Table 297. South America Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2021-2026)
  • Table 298. South America Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2021-2026)
  • Table 299. Brazil Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2021-2026)
  • Table 300. Brazil Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2021-2026)
  • Table 301. Brazil Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2021-2026)
  • Table 302. Argentina Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2021-2026)
  • Table 303. Argentina Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2021-2026)
  • Table 304. Argentina Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2021-2026)
  • Table 305. Rest of South America Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2021-2026)
  • Table 306. Rest of South America Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2021-2026)
  • Table 307. Rest of South America Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2021-2026)
  • Table 308. Asia Pacific Porcine Epidemic Diarrhea Vaccines Sales, by Country K Units (2021-2026)
  • Table 309. Asia Pacific Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2021-2026)
  • Table 310. Asia Pacific Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2021-2026)
  • Table 311. Asia Pacific Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2021-2026)
  • Table 312. China Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2021-2026)
  • Table 313. China Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2021-2026)
  • Table 314. China Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2021-2026)
  • Table 315. Japan Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2021-2026)
  • Table 316. Japan Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2021-2026)
  • Table 317. Japan Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2021-2026)
  • Table 318. India Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2021-2026)
  • Table 319. India Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2021-2026)
  • Table 320. India Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2021-2026)
  • Table 321. South Korea Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2021-2026)
  • Table 322. South Korea Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2021-2026)
  • Table 323. South Korea Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2021-2026)
  • Table 324. Taiwan Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2021-2026)
  • Table 325. Taiwan Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2021-2026)
  • Table 326. Taiwan Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2021-2026)
  • Table 327. Australia Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2021-2026)
  • Table 328. Australia Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2021-2026)
  • Table 329. Australia Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2021-2026)
  • Table 330. Rest of Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2021-2026)
  • Table 331. Rest of Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2021-2026)
  • Table 332. Rest of Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2021-2026)
  • Table 333. Europe Porcine Epidemic Diarrhea Vaccines Sales, by Country K Units (2021-2026)
  • Table 334. Europe Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2021-2026)
  • Table 335. Europe Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2021-2026)
  • Table 336. Europe Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2021-2026)
  • Table 337. Germany Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2021-2026)
  • Table 338. Germany Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2021-2026)
  • Table 339. Germany Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2021-2026)
  • Table 340. France Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2021-2026)
  • Table 341. France Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2021-2026)
  • Table 342. France Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2021-2026)
  • Table 343. Italy Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2021-2026)
  • Table 344. Italy Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2021-2026)
  • Table 345. Italy Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2021-2026)
  • Table 346. United Kingdom Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2021-2026)
  • Table 347. United Kingdom Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2021-2026)
  • Table 348. United Kingdom Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2021-2026)
  • Table 349. Netherlands Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2021-2026)
  • Table 350. Netherlands Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2021-2026)
  • Table 351. Netherlands Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2021-2026)
  • Table 352. Rest of Europe Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2021-2026)
  • Table 353. Rest of Europe Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2021-2026)
  • Table 354. Rest of Europe Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2021-2026)
  • Table 355. MEA Porcine Epidemic Diarrhea Vaccines Sales, by Country K Units (2021-2026)
  • Table 356. MEA Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2021-2026)
  • Table 357. MEA Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2021-2026)
  • Table 358. MEA Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2021-2026)
  • Table 359. Middle East Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2021-2026)
  • Table 360. Middle East Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2021-2026)
  • Table 361. Middle East Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2021-2026)
  • Table 362. Africa Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2021-2026)
  • Table 363. Africa Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2021-2026)
  • Table 364. Africa Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2021-2026)
  • Table 365. North America Porcine Epidemic Diarrhea Vaccines Sales, by Country K Units (2021-2026)
  • Table 366. North America Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2021-2026)
  • Table 367. North America Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2021-2026)
  • Table 368. North America Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2021-2026)
  • Table 369. United States Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2021-2026)
  • Table 370. United States Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2021-2026)
  • Table 371. United States Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2021-2026)
  • Table 372. Canada Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2021-2026)
  • Table 373. Canada Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2021-2026)
  • Table 374. Canada Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2021-2026)
  • Table 375. Mexico Porcine Epidemic Diarrhea Vaccines Sales, by Type K Units (2021-2026)
  • Table 376. Mexico Porcine Epidemic Diarrhea Vaccines Sales, by Application K Units (2021-2026)
  • Table 377. Mexico Porcine Epidemic Diarrhea Vaccines Sales, by End Users K Units (2021-2026)
  • Table 378. Porcine Epidemic Diarrhea Vaccines: by Type(USD/Units)
  • Table 379. Research Programs/Design for This Report
  • Table 380. Key Data Information from Secondary Sources
  • Table 381. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Porcine Epidemic Diarrhea Vaccines: by Type USD Million (2015-2020)
  • Figure 5. Global Porcine Epidemic Diarrhea Vaccines: by Application USD Million (2015-2020)
  • Figure 6. Global Porcine Epidemic Diarrhea Vaccines: by End Users USD Million (2015-2020)
  • Figure 7. South America Porcine Epidemic Diarrhea Vaccines Share (%), by Country
  • Figure 8. Asia Pacific Porcine Epidemic Diarrhea Vaccines Share (%), by Country
  • Figure 9. Europe Porcine Epidemic Diarrhea Vaccines Share (%), by Country
  • Figure 10. MEA Porcine Epidemic Diarrhea Vaccines Share (%), by Country
  • Figure 11. North America Porcine Epidemic Diarrhea Vaccines Share (%), by Country
  • Figure 12. Global Porcine Epidemic Diarrhea Vaccines: by Type K Units (2015-2020)
  • Figure 13. Global Porcine Epidemic Diarrhea Vaccines: by Application K Units (2015-2020)
  • Figure 14. Global Porcine Epidemic Diarrhea Vaccines: by End Users K Units (2015-2020)
  • Figure 15. South America Porcine Epidemic Diarrhea Vaccines Share (%), by Country
  • Figure 16. Asia Pacific Porcine Epidemic Diarrhea Vaccines Share (%), by Country
  • Figure 17. Europe Porcine Epidemic Diarrhea Vaccines Share (%), by Country
  • Figure 18. MEA Porcine Epidemic Diarrhea Vaccines Share (%), by Country
  • Figure 19. North America Porcine Epidemic Diarrhea Vaccines Share (%), by Country
  • Figure 20. Global Porcine Epidemic Diarrhea Vaccines: by Type USD/Units (2015-2020)
  • Figure 21. Global Porcine Epidemic Diarrhea Vaccines share by Players 2020 (%)
  • Figure 22. Global Porcine Epidemic Diarrhea Vaccines share by Players (Top 3) 2020(%)
  • Figure 23. Global Porcine Epidemic Diarrhea Vaccines share by Players (Top 5) 2020(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Cavac (France) Revenue, Net Income and Gross profit
  • Figure 26. Cavac (France) Revenue: by Geography 2020
  • Figure 27. Green Cross Zoetis Products (South Korea) Revenue, Net Income and Gross profit
  • Figure 28. Green Cross Zoetis Products (South Korea) Revenue: by Geography 2020
  • Figure 29. Harrisvaccines, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Harrisvaccines, Inc. (United States) Revenue: by Geography 2020
  • Figure 31. Komipharm (South Korea) Revenue, Net Income and Gross profit
  • Figure 32. Komipharm (South Korea) Revenue: by Geography 2020
  • Figure 33. Nisseiken Co. Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 34. Nisseiken Co. Ltd. (Japan) Revenue: by Geography 2020
  • Figure 35. Qilu Animal Health (China) Revenue, Net Income and Gross profit
  • Figure 36. Qilu Animal Health (China) Revenue: by Geography 2020
  • Figure 37. KM Biologics Co. Ltd (United States) Revenue, Net Income and Gross profit
  • Figure 38. KM Biologics Co. Ltd (United States) Revenue: by Geography 2020
  • Figure 39. Bayer AG (United States) Revenue, Net Income and Gross profit
  • Figure 40. Bayer AG (United States) Revenue: by Geography 2020
  • Figure 41. Global Porcine Epidemic Diarrhea Vaccines: by Type USD Million (2021-2026)
  • Figure 42. Global Porcine Epidemic Diarrhea Vaccines: by Application USD Million (2021-2026)
  • Figure 43. Global Porcine Epidemic Diarrhea Vaccines: by End Users USD Million (2021-2026)
  • Figure 44. South America Porcine Epidemic Diarrhea Vaccines Share (%), by Country
  • Figure 45. Asia Pacific Porcine Epidemic Diarrhea Vaccines Share (%), by Country
  • Figure 46. Europe Porcine Epidemic Diarrhea Vaccines Share (%), by Country
  • Figure 47. MEA Porcine Epidemic Diarrhea Vaccines Share (%), by Country
  • Figure 48. North America Porcine Epidemic Diarrhea Vaccines Share (%), by Country
  • Figure 49. Global Porcine Epidemic Diarrhea Vaccines: by Type K Units (2021-2026)
  • Figure 50. Global Porcine Epidemic Diarrhea Vaccines: by Application K Units (2021-2026)
  • Figure 51. Global Porcine Epidemic Diarrhea Vaccines: by End Users K Units (2021-2026)
  • Figure 52. South America Porcine Epidemic Diarrhea Vaccines Share (%), by Country
  • Figure 53. Asia Pacific Porcine Epidemic Diarrhea Vaccines Share (%), by Country
  • Figure 54. Europe Porcine Epidemic Diarrhea Vaccines Share (%), by Country
  • Figure 55. MEA Porcine Epidemic Diarrhea Vaccines Share (%), by Country
  • Figure 56. North America Porcine Epidemic Diarrhea Vaccines Share (%), by Country
  • Figure 57. Global Porcine Epidemic Diarrhea Vaccines: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Cavac (France)
  • Green Cross Zoetis Products (South Korea)
  • Harrisvaccines, Inc. (United States)
  • Komipharm (South Korea)
  • Nisseiken Co. Ltd. (Japan)
  • Qilu Animal Health (China)
  • KM Biologics Co. Ltd (United States)
  • Bayer AG (United States)
Additional players considered in the study are as follows:
Zoetis (United States) , Ceva Sante Animale (France) , Aptimmune Biologics Inc. (United States)
Select User Access Type

Key Highlights of Report


May 2021 248 Pages 95 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Porcine Epidemic Diarrhea Vaccines Quantitative research analysis
Global Porcine Epidemic Diarrhea Vaccines Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Rise in Number of Pig Farms " is seen as one of major growth factors of Porcine Epidemic Diarrhea Vaccines Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

Know More About Global Porcine Epidemic Diarrhea Vaccines Report?

Have a Query? Click Here

Other Related Reports

Medical Cannabis Comprehensive Study by Active Ingredients (Tetrahydrocannabinol {THC}, Cannabidiol {CBD}), Point of Sale (Dispensaries, Online Pharmacy, Hospital Pharmacy), Therapeutic Application (...
$ 3650
Dementia Drugs Comprehensive Study by Type (MAO Inhibitors, Cholinesterase Inhibitors, Glutamate Inhibitors), Application (Hospital, Clinics, Others), Indication (Lewy Body Dementia, Parkinsons Disea...
$ 3650
Liposome Drug Delivery Comprehensive Study by Type (Liposomal Doxorubicin, Liposomal Amphotericin B, Liposomal Paclitaxel), Application (Pharmaceutical, Cosmetic, Food, Farming), Therapy (Fungal Infe...
$ 3350
Anti-infective Agents Comprehensive Study by Type (Antibacterial Drugs, Antifungal Drugs, Antiviral Drugs), Application (Hospital Use, Clinic Use, Household, Other), Drug Type (Penicillins, Sulfonami...
$ 3750
Legal Marijuana Comprehensive Study by Type (Indoor, Greenhouse), Application (Chronic Pain, Mental Disorders, Cancer, Others), End-Users (Healthcare Industry, Recreational Industry, Others) Players ...
$ 3500
Veterinary Drugs Comprehensive Study by Type (Antibiotics, Non-Steroidal Anti-Inflammatories, Steroids, Opioid Pain Relievers, Anti-Parasitics, Behavior-Modifying Drugs and Sedatives, Hormones, Chemo...
$ 3750